Correlation Between Bristol Myers and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Myriad Genetics, you can compare the effects of market volatilities on Bristol Myers and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Myriad Genetics.

Diversification Opportunities for Bristol Myers and Myriad Genetics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bristol and Myriad is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Myriad Genetics go up and down completely randomly.

Pair Corralation between Bristol Myers and Myriad Genetics

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.48 times more return on investment than Myriad Genetics. However, Bristol Myers Squibb is 2.09 times less risky than Myriad Genetics. It trades about 0.16 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.14 per unit of risk. If you would invest  5,668  in Bristol Myers Squibb on November 5, 2024 and sell it today you would earn a total of  227.00  from holding Bristol Myers Squibb or generate 4.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Myriad Genetics

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bristol Myers and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Myriad Genetics

The main advantage of trading using opposite Bristol Myers and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Bristol Myers Squibb and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity